Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. ACN

Go back to Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign
(NASDAQ: ALLR) Delayed: 1.17 -0.04 (3.31%)
Previous Close $1.21    52 Week High $ 
Open $1.20    52 Week Low $ 
Day High $1.20    P/E N/A 
Day Low $1.13    EPS $ 
Volume 115,119       

(NASDAQ: ALLR) Delayed: 1.17 -0.04 (3.31%)
Previous Close $1.21    52 Week High $ 
Open $1.20    52 Week Low $ 
Day High $1.20    P/E N/A 
Day Low $1.13    EPS $ 
Volume 115,119